Advertisement
Sino Biological
Sino Biological

The Scientist

» FDA and developmental biology

Most Recent

image: How Safe Is Your Medicine Cabinet?

How Safe Is Your Medicine Cabinet?

By | May 1, 2013

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

1 Comment

image: Branching Out

Branching Out

By | April 1, 2013

Satellites of the Golgi apparatus generate the microtubules used to grow outer dendrite branches in Drosophila neurons.

0 Comments

image: Pluripotent Until Needed

Pluripotent Until Needed

By | April 1, 2013

Microarrays help keep induced pluripotent stem cell lines in check, from start to finish.

0 Comments

image: Smurf-y Old Age

Smurf-y Old Age

By | April 1, 2013

Flies turning blue help researchers link the deterioration of the intestinal barrier to age-related death.

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: All In Proportion

All In Proportion

By | March 2, 2013

Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.

0 Comments

image: Contributors

Contributors

By | March 1, 2013

Meet some of the people featured in the March 2013 issue of The Scientist.

0 Comments

image: Instant Messaging

Instant Messaging

By | March 1, 2013

During development, communication between organs determines their relative final size.

2 Comments

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

image: Stem-Cell Clinic Moves to Mexico

Stem-Cell Clinic Moves to Mexico

By | February 1, 2013

A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.  

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Mettler Toledo
BD Biosciences
BD Biosciences